Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIB-IMRT plus concurrent chemotherapy in limited-stage small cell lung cancer
ChiCTR2100053931Phase 2Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Sep 2015
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of etoposide, cisplatin and carboplatin in small cell lung cancer (SCLC), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: local-regional control. Started Sep 2015; status: recruiting.
02
Drugs
etoposidecisplatincarboplatin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on ChiCTR2100053931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053931.